Visit COVID-19 resources

[Skip to Content]

Fluocinolone acetonide

Fluocinolone acetonide intravitreal implant for treating chronic DMO after inadequate response to prior therapy

Dec 30
2014

College statement on NICE guidance TA 301 – Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after inadequate response to prior therapy (rapid review of technology appraisal guidance 271) December 2013

  • 30 December 2014